Impact ofSLCO1B1(OATP1B1) andABCG2(BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins

A Review of Lipid Management in Primary and Secondary Prevention

(2013) Ewa Dembowski et al.   Journal of Cardiopulmonary Rehabilitation and Prevention

Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients

(2010) Guo-ping Yang et al.   ACTA PHARMACOLOGICA SINICA

Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction

(2010) Kristian M. Bailey et al.   Circulation-Cardiovascular Genetics

ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

(2010) B Tomlinson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Hepatitis C Virus-related Cirrhosis is a Major Determinant of the Expression Levels of Hepatic Drug Transporters

(2010) Ken Ogasawara et al.   Drug Metabolism and Pharmacokinetics

Efflux and uptake transporters as determinants of statin response

(2010) Alice C Rodrigues   Expert Opinion on Drug Metabolism & Toxicology

Treatment of dyslipidemia in HIV-infected patients

(2010) Rajagopal V Sekhar et al.   EXPERT OPINION ON PHARMACOTHERAPY

Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

(2010) C. D. Klaassen et al.   PHARMACOLOGICAL REVIEWS

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1

(2010) P. Annaert et al.   XENOBIOTICA

Differential effect of genetic variants of Na+-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors

(2010) Min-Koo Choi et al.   XENOBIOTICA

Global and regional causes of death

(2009) C. D. Mathers et al.   BRITISH MEDICAL BULLETIN

Heart Disease and Stroke Statistics—2009 Update

(2009) et al.   CIRCULATION

Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins

(2009) Michael J. Knauer et al.   CIRCULATION RESEARCH

Transporter Pharmacogenetics and Statin Toxicity

(2009) M Niemi   CLINICAL PHARMACOLOGY & THERAPEUTICS

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

(2009) J E Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Managing Statin Myopathy

(2009) Carmelo V. Venero et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs

(2009) Ichiro Ieiri et al.   Expert Opinion on Drug Metabolism & Toxicology

Toxic and drug-induced myopathies

(2009) M C Dalakas   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects

(2009) Deepak Voora et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rhabdomyolysis and Acute Kidney Injury

(2009) Xavier Bosch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

(2009) Jenni E Keskitalo et al.   PHARMACOGENOMICS

Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin

(2008) Pertti J Neuvonen et al.   CLINICAL PHARMACOKINETICS

New insights into mechanisms of statin-associated myotoxicity

(2008) P SIRVENT et al.   CURRENT OPINION IN PHARMACOLOGY

Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin

(2008) S. Kitamura et al.   DRUG METABOLISM AND DISPOSITION

Drug/Drug Interaction Between Lopinavir/Ritonavir and Rosuvastatin in Healthy Volunteers

(2008) Jennifer J Kiser et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Association between risk of myopathy and cholesterol-lowering effect: A comparison of all statins

(2008) Masaki Kobayashi et al.   LIFE SCIENCES

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy

(2008) Philippe Couvert et al.   PHARMACOGENOMICS